➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

Patent: 9,920,604

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,920,604
Title:Wellbore fluids comprising mineral particles and methods relating thereto
Abstract: Mineral particles may provide for wellbore fluids with tailorable properties and capabilities, and methods relating thereto. Mineral particles may be utilized in methods that include introducing a wellbore fluid having a density of about 7 ppg to about 50 ppg into a wellbore penetrating a subterranean formation, the wellbore fluid comprising a base fluid and a plurality of mineral particles, and the wellbore fluid having a first viscosity; contacting at least some of the mineral particles with a linking agent so as to link the at least some of the mineral particles, thereby increasing the first viscosity to a second viscosity.
Inventor(s): Jamison; Dale E. (Houston, TX), Landis; Charles (Houston, TX), Deville; Jay (Houston, TX), McDaniel; Cato (Houston, TX)
Assignee: Halliburton Energy Services, Inc. (Houston, TX)
Application Number:14/940,472
Patent Claims:see list of patent claims

Details for Patent 9,920,604

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Pharmalucence MICROLITE technetium tc-99m albumin colloid kit INJECTABLE;INJECTION 018263 001 1983-05-31   Start Trial Halliburton Energy Services, Inc. (Houston, TX) 2040-03-31 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,920,604

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.